Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis

Cancer and Metastasis Reviews

Volumn 15, Issue 2, 1996, Pages 165-176

  Claffey, Kevin P ^a   Robinson, Gregory S ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HYBRIDON INC   (United States)

Author keywords

Angiogenesis; Cancer; Hypoxia; Melanoma; Metastasis; VEGF; VPF

Indexed keywords

CYTOKINE; VASCULOTROPIN;

ANGIOGENESIS; CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; HYPOXIA; MELANOMA; METASTASIS; ONCOGENE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030054914     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00437469     Document Type: Review

References (108)

1. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov DC, Armellino D, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosino kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Comm 187: 1579-1586, 1992
2. Quinn TP, Peters KG, De Ferrara VC, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537, 1993
3. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K: The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 178: 2077-2088, 1993
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
5. Mustonen, T, Alitulo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898, 1995
6. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruher RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84; 1470-1478. 1989
7. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989
8. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm 161: 851-858, 1989
9. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeplides. J Cell Biochem 47: 211-218, 1991
10. Ferrara N, Leung DW, Cachianes G, Winter J, Henzel WJ: Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol 198: 391-405, 1991
11. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311-7315, 1989
12. Conn G, Soderman DD, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA: Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87: 1323-1327, 1990
13. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA: Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci 87: 2628-2632, 1990
14. - and von Willibrand factor release in human endothelial cells. Am J Pathol 138: 213-221, 1991
15. Unemori EN, Ferrara N, Bauer EA, Amento EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Phys 153: 557-562, 1992
16. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Comm 181: 902-906, 1991
17. Mandriota SJ, Seghezzi G, Vassalli J-D, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270: 9709-9716, 1995
18. 3 integrin, osteopontin, and thrombin. Am J Path, In Press, 1996
19. Guo D, Jia Q, Song HY, Warren RS, Donner DB: Vascular endothelial growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 270: 6729-6733, 1995
20. Neel BG: Structure and function of SH2-domain containing tyrosine phosphatases. 4: 419-432, 1993
21. Schaffhausen B: SH2 domain structure and function. Biochim Biophys Acta 1242: 61-75, 1995
22. 3 for angiogenesis. Science 264: 569-571, 1994
23. 3 antagonists promote tumor regression by inducing apoptosis of angio-genic blood vessels. Cell 79: 1157-1164, 1994
24. Constantini V, Zarcharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM: Fibrinogen deposition without thrombin generation in primary breast cancer tissue. Cancer Res 51: 349-353, 1991
25. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50: 1774-1778, 1990
26. Dvorak HF, Senger DR, Dvorak AM: Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metas Rev 2: 41-73, 1983
27. Dvorak HF, Harvey VS, McDonagh J: Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res 44: 3348-3354, 1984
28. Dvorak HF, Senger DR, Dvorak AM: Fibrin formation: implications for tumor growth and metastasis. In: Honn KV, Sloane BF (eds) Hemostatic Mechanisms and Metastasis. Martinus Nijhoff Publishing, Boston, pp 96-114
29. Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo K-T, Yeo T-K, Dvorak AM, Van De Water L, Sioussat TM, Senger DR: Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 667: 101-111, 1992
30. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo K-T, Yeo T-K, Sioussat TM, Dvorak HF: Pathogenesis of ascites tumor growth. Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res 55: 360-368, 1995
31. Nagy JA, Morgan EM, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF: Pathogenesis of ascites tumor growth. Angiogenesis, vascular remodeling and stroma formation in the peritoneal lining. Cancer Res 55: 376-385, 1995
32. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983
33. Weindel K, Moringlane JR, Marme D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 35: 439-449, 1994
34. Yeo K-T, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo T-K: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53: 2912-2918, 1993
35. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Theime H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994
36. 165 and PDGF-BB. Anatomy and Embryology 186: 251-257, 1992
37. Zhang H-T, Craft P, Scott PAE, Ziehe M, Weich HA, Harris AL, Bicknell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells. J Natl Can Inst 87: 213-218, 1995
38. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
39. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrin 5:1806-1814, 1991
40. Park J, Keller G-A, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subendothelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326, 1993
41. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037, 1992
42. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992
43. Claffey KP, Wilkison WO, Spiegelman BM: Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267: 16317-16322, 1992
44. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379, 1992
45. Charnock-Jones D, Sharkey A, Rajput-Williams J, Burch D, Schofield J, Fountain S, Boocock C, Smith S: Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 48: 1120-1128, 1993
46. Cullinan-Bove K, Koos R: Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133: 829-837, 1993
47. Phillips HS, Hains J, Leung DW, Ferrara N: Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127: 965-967, 1990
48. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theea lutein cells: role in corpus luteum development. Am J Path 146: 157-165, 1995
49. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznik AJ: Vascular endothelial growth factor messenger ribonucleic acid expression in the primary ovary. Endocrinology 131: 254-260, 1992
50. Olson TA, Mohanraj D, Carson LF, Ramakrishnan S: Vascular permeability factor gene expression in normal and neoplaslic human ovaries. Cancer Res 54: 276-280, 1994
51. Koos RD: Increased expression of vascular endothelial growth factor/vascular permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod 52: 1426-1435, 1995
52. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994
53. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274, 1994
54. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92: 11-14, 1995
55. Stavri GT, Hong Y, Zachary IC, Brier G, Baskerville PA, Yla-Herttuala S, Risau W, Martin JF, Erusalimsky JD: Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358: 311-315, 1995
56. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and conformation of bovine capillary endothelial cells with collagen gels. Lab Invest 69: 508-517, 1993
57. Detmar M, Brown L, Claffey K, Yeo K-T, Kocher O, Jackman R, Berse B, Dvorak H: Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 180: 1141-1146, 1994
58. Koos RD, Olson CE: Hypoxia stimulates expression of the gene for vascular endothelial growth factor (VEGF), a putative angiogenic factor, by granulosa cells of the ovarian follicle, a site of angiogenesis [abstract]. J Cell Biol 115: 421a, 1991
59. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
60. Ladoux A, Frelin C: Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195: 1005-1010, 1993
61. Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R, Kira Y: Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 204: 318-324, 1994
62. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y: Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267: h1948-1954, 1994
63. Nomura M, Yamagishi S-I, Harada S-I, Hayashi Y, Yamashima T, Yamashita J, Yamamoto H: Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 370: 28316-28324, 1995
64. Alon T, Memo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1: 1024-1028, 1995
65. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15: 4738-4747, 1995
66. Pierce EA, Mukai S: Controversies in the management of retinopathy of prematurity. Int Ophthal Clinics 34: 121-148, 1994
67. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92: 905-909, 1995
68. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993
69. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262, 1993
70. Senger D, Van De Water L, Brown L, Nagy J, Yeo K-T, Yeo T-K, Berse B, Jackman R, Dvorak A, Dvorak H: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metas Rev 12: 303-324, 1993
71. Brown L, Berse B, Jackman R, Tognazzi K, Guidi A, Dvorak H, Senger D, Connolly J, Schnitt S: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathol 26: 86-91, 1995
72. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992
73. Keiser A, Weich HA, Brandner G, Marme D, Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994
74. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, Isner JM: Hypoxia induces vascular endothelial growth factor in cultured endothelial cells. J Biol Chem 270: 31189-31195, 1995
75. Sugihara T, Kaul SC, Mitsui Y, Wadhwa R: Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts. Biochem Biophys Acta 1224: 365-370, 1994
76. Zhang G, Sato JD, Herley MT, Tsang MW, Ye H, Liu H, Ichimura T, Yan G, McKeehan WL, Stevens JL: Stable and temperature-sensitive transformation of rat kidney epithelial cells suppress expression of acidic fibroblast growth factor 1 but activates secretion of fibroblast growth factor 3 (int-2) and vascular endothelial growth factor. Cell Growth Differ 5: 349-357, 1994
77. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D: Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 270: 25915-25919, 1995
78. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580, 1995
79. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995
80. Levine AJ, Momand J, Finlay CA: The p53 suppressor gene. Nature 351: 453-456, 1991
81. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991
82. Sidransky D, Mikkelson T, Schwechleimer K, Rosenhlum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846-847, 1992
83. Fava R, Olsen N, Spencer-Green G, Yeo K-T, Yeo T-K, Berse B, Jackman R, Senger D, Dvorak H, Brown L: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180: 341-346, 1994
84. Li XF, Gregory J, Ahmed A: Immunolocalization of vascular endothelial growth factor in human endometrium. Growth Factors 11: 277-282, 1994
85. Chakraborty I, Das SK, Dey SK: Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. J Endocrinol 147: 339-352, 1995
86. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marme D, Breckwoldt M: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80: 1967-1971, 1995
87. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766, 1995
88. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15: 5363-5368, 1995
89. Wang GL, Semenza GL: Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268: 21513-21518, 1993
90. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269: 4355-4359, 1994
91. Minchenko A, Saceda S, Bauer T, Caro J: Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40: 35-39, 1994
92. Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res 77: 638-643, 1995
93. Nagy JA, Masse EM, Harvey-Bliss VS, Meyers MS, Sioussat TM, Senger DR, Dvorak HF: Immunohistochemical localization of vascular permeability factor (vascular endothelial growth factor) in ascites tumors: distribution in peritoneal wall microvasculature. J Cell Biol 115: 264a, 1991
94. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993
95. Millauer B, Shawver L, Plate K, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994
96. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EJ, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 56: 172-181, 1996
97. Potgens AJ, van Lubsen NH, Schoenmakers JG, Ruiter DJ, de Waal RMW: Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 146: 197-209, 1995
98. Folkman J, Klagsburn M, Angiogenic factors. Science 235: 442-447, 1987
99. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992
100. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992
101. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995
102. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation of vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1807, 1995
103. 121. Cancer Res 55:5296-5301, 1995
104. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994
105. Guidi AJ, Fascher L, Harris JR, Schnitt SJ: Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86: 614-619, 1994
106. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen S-C, Skinner DG, Nichols PW: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87: 1603-1612, 1995
107. Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer 1: 961-964, 1995
108. Toi M, Inada K, Suzuki H, Tominaga T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res & Treat 36: 193-204, 1995